Research programme: cardiology diagnostics - BTG

Drug Profile

Research programme: cardiology diagnostics - BTG

Alternative Names: BGC-C2I molecular imaging probe; Cardiology diagnostics research programme - BTG

Latest Information Update: 07 May 2007

Price : $50

At a glance

  • Originator BTG
  • Class Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Coronary artery disease

Most Recent Events

  • 07 May 2007 No development reported - Preclinical for Coronary artery disease (diagnosis) in USA (unspecified route)
  • 01 Mar 2004 The programme is available for licensing in in Europe and North America (http://www.btgplc.com)
  • 01 Mar 2004 Preclinical trials in Coronary artery disease (diagnosis) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top